CONMED (CNMD) revenue breakdown
By product, General Surgery is the largest at 58% of fiscal 2025 revenue, growing 10% a year over 9 years.
By region, United States is the largest at 56% of fiscal 2025 revenue, growing 8% a year over 9 years.
Revenue by product
Fiscal years, as CONMED reports them in its 10-K filings; fiscal 2025 total $1.4B.
| Products | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| General Surgery | $341M | $367M | $413M | $492M | $488M | $572M | $584M | $712M | $763M | $800M | 58% |
| Orthopedic Surgery | $422M | $429M | $447M | $463M | $375M | $438M | $462M | $533M | $544M | $575M | 42% |
Revenue by region
Fiscal years, as CONMED reports them in its 10-K filings; fiscal 2025 total $1.4B.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $399M | $411M | $449M | $517M | $482M | $553M | $579M | $700M | $748M | $775M | 56% |
| EMEA | $148M | $156M | $167M | $183M | $161M | $190M | $198M | $226M | $243M | $265M | 19% |
| Asia Pacific | $129M | $138M | $147M | $161M | $141M | $171M | $162M | $197M | $195M | $209M | 15% |
| Americas (excluding the United States) | $88M | $91M | $98M | $95M | $79M | $97M | $106M | $121M | $121M | $127M | 9% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for CNMD.
Open CNMD in InvestinglyQuestions
Where does CONMED make its money?
In fiscal 2025, by product: General Surgery $800M, Orthopedic Surgery $575M.
From CONMED's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.